Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial

Document Type : Original

Authors

1 Department of Physical Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

2 Department of Neurology, School of Medicine Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Introduction: 
Chronic facial nerve palsy has long been known to negatively affect the quality of life in patients. The present study aimed to investigate the efficacy of Botulinum Toxin A (BTX-A) and neuromuscular retraining therapy (NMRT) in the symmetry of chronic facial palsy.
Materials and Methods:
Two groups, namely experimental and control, were considered each consisting of 13 patients. The study population included a total of 15 female subjects. The BTX-A was injected into the synkinetic muscle in the experimental group; nevertheless, the patients in the second group participated in special neuromuscular retraining. The rate of reducing synkinesis and symmetrical improvement was evaluated using the Facial Grading System (FGS) after 4 months of treatment. The independent t-test was performed to compare the two groups.
Results:
According totheSunnybrook FGS,the mean changes in Sunnybrook scores in the experimental and neuromuscular retraining groups were 3% and 24%, respectively. The comparison of the mean scores of the two groups was statistically significant after the interventions (P=0.033). A variable ratio of statistically significant improvement was observed in synkinesis in both groups following the treatment (P=0.041). In addition, by comparing the synkinesis scores between the two groups, the reduction of synkinesis was observed to be greater in the neuromuscular retraining group (P=0.041) after the treatment.
Conclusions:
The findings of the current study indicated that special neuromuscular retraining leads to significant improvement in the FGS score, compared to botulinum toxin therapy alone. Moreover, it was observed that facial symmetry can be treated with special neuromuscular retraining and the patient can overcome synkinesis.

Keywords

References

  1. Cronin GW, Steenerson RL. The effectiveness of neuromuscular facial retraining combined with electromyography in facial paralysis rehabilitation. Otolaryngol Head Neck Surg.  2003; 128: 534-8.
  2. May M. Microanatomy and pathophysiology. In: May M, editor. The Facial Nerve.2nd ed New York: Thieme; 2000. p. 57-65.
  3. Bylund N, Jensson D, Enghag S, Berg T, Marsk E, Hultcrantz M,eal. Synkinesis in Bell's palsy in a randomized controlled trial. Clin Otolaryngol. 2017;42: 673-80.
  4. Husseman J, Metha RP.  Management of synkinesis.  Facial Plast Surg 2008;:242-9.
  5. Celik M, Forta H, Vural C. The development of synkinesis after facial nerve paralysis. Eur Neurol. 2000;43: 147-51
  6. Pourmomeny AA, Asadi S, Cheatsaz A. Management of facial synkinesis with a combination of BTX-A and biofeedback: a randomized trial. Iran J Otorhinolaryngol. 2015; 27:409-415.
  7. Cabin JA, Massry GG, Azizzadeh B. Botulinum toxin in the management of facial paralysis. Current opinion in otolaryngol  head neck surg.2015;23:272-80.
  8. Beurskens CH G, Heymans PG. Positive Effects of Mime Therapy on Sequelae of Facial Paralysis: Stiffness, Lip Mobility, and Social and Physical Aspects of Facial Disability. Otol Neurotol. 2003; 24: 677-81.
  9. Kim J. Contralateral botulinum toxin injection to improve facial asymmetry after acute facial paralysis. Otol & Neurotol. 2013; 34:319-24.
  10. Sadiq SA, Khwaja S, Saeed SR. Botulinum toxin to improve lower facial symmetry in facial nerve palsy. Eye 2012;26:1431.
  11. do Nascimento Remigio AF, Salles AG, de Faria J CM, Ferreira MC. Comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA at the 1: 3 conversion ratio for the treatment of asymmetry after long-term Plast Reconstr Surg. 2015; 135:239-49. 
  12. Couch SM, Chundury RV, Holds JB. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox). Ophthalmic Plast Reconstr Surg. 2014; 30:246-50.
  13. Schaitkin B, Eisenman D. Anatomy of Facial Muscles. In: May M SB, editor. The Facial Nerve. 2nd ed. ed. New Yourk: Thieme; 2000. p. 95-105.
  14. Van Swearingen Jessie. Facial Rehabilitation: A Neuromuscular Reeducation, Patient-Centered Approach. Facial Plastic Surgery 2008; 24:250-9.
  15. Rogers CR, Schmidt KL, Van Swearingen JM, Cohn JF, Wachtman GS, Manders EK, et al. Automated facial image analysis: detecting improvement in abnormal facial movement after treatment with botulinum toxin A. Ann Plast Surg. 2007;58:39-47.
  16. Ito H, Nakano S, Kusaka H. Low- dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation. Acta neurologica scandinavica. 2007; 115:271-4.

 

 

 

 

Iranian Journal of Otorhinolaryngology
Volume 33, Issue 3
May and June 2021
Pages 151-155

Files

Share

How to cite

Statistics